Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norman Wolmark

Showing results (21-30 of 232) with videos related to

Pageof 24
Sort By:
Journal of the National Cancer Institute|July 5, 2006
Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trialNeil Abramson, Joseph P Costantino, Judy E Garber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 29, 2004
Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trialsAlphonse Taghian, Jong-Hyeon Jeong, Eleftherios Mamounas, et al.
Breast Cancer Research and Treatment|October 3, 2008
Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancerJames J Dignam, Vanja Dukic, Stewart J Anderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2002
Association of tamoxifen and uterine sarcomaD Lawrence Wickerham, Bernard Fisher, Norman Wolmark, et al.
Chinese Clinical Oncology|March 14, 2017
Milestone clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP)Priya Rastogi, D Lawrence Wickerham, Charles E Geyer, et al.
Lancet (London, England)|September 8, 2004
Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trialsBernard Fisher, Jong-Hyeon Jeong, John Bryant, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2003
Prognosis after rectal cancer in blacks and whites participating in adjuvant therapy randomized trialsJames J Dignam, Yunrong Ye, Linda Colangelo, et al.
Journal of the National Cancer Institute|November 16, 2006
Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancerJames J Dignam, Blase N Polite, Greg Yothers, et al.
Breast Cancer Research and Treatment|September 14, 2007
Symptom measurement in the Breast Cancer Prevention Trial (BCPT) (P-1): psychometric properties of a new measure of symptoms for midlife womenDavid Cella, Stephanie R Land, Chih-Hung Chang, et al.
Journal of the National Cancer Institute|November 1, 2015
Time-Varying Effects of Breast Cancer Adjuvant Systemic TherapyIsmail Jatoi, Hanna Bandos, Jong-Hyeon Jeong, et al.
Pageof 24

Showing results (21-30 of 232) with videos related to

Sort By:
Pageof 24
Journal of the National Cancer Institute|July 5, 2006
Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trialNeil Abramson, Joseph P Costantino, Judy E Garber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 29, 2004
Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trialsAlphonse Taghian, Jong-Hyeon Jeong, Eleftherios Mamounas, et al.
Breast Cancer Research and Treatment|October 3, 2008
Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancerJames J Dignam, Vanja Dukic, Stewart J Anderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2002
Association of tamoxifen and uterine sarcomaD Lawrence Wickerham, Bernard Fisher, Norman Wolmark, et al.
Chinese Clinical Oncology|March 14, 2017
Milestone clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP)Priya Rastogi, D Lawrence Wickerham, Charles E Geyer, et al.
Lancet (London, England)|September 8, 2004
Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trialsBernard Fisher, Jong-Hyeon Jeong, John Bryant, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2003
Prognosis after rectal cancer in blacks and whites participating in adjuvant therapy randomized trialsJames J Dignam, Yunrong Ye, Linda Colangelo, et al.
Journal of the National Cancer Institute|November 16, 2006
Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancerJames J Dignam, Blase N Polite, Greg Yothers, et al.
Breast Cancer Research and Treatment|September 14, 2007
Symptom measurement in the Breast Cancer Prevention Trial (BCPT) (P-1): psychometric properties of a new measure of symptoms for midlife womenDavid Cella, Stephanie R Land, Chih-Hung Chang, et al.
Journal of the National Cancer Institute|November 1, 2015
Time-Varying Effects of Breast Cancer Adjuvant Systemic TherapyIsmail Jatoi, Hanna Bandos, Jong-Hyeon Jeong, et al.
Pageof 24